한글목차

세계 바이오의약품 산업의 2022년 시장 규모는 COVID-19의 영향으로부터 회복하고, 많은 기업에 있어서 재조정과 이동의 해가 될 것으로 예상됩니다.

세계의 2022년 바이오의약품(Biopharmaceutical) 산업 시장을 조사했으며, 시장 규모와 예측, 동향, 기업 정보 등의 정보를 제공합니다.

목차

목차

제1장 조사 디자인

• 응답자 믹스
• 목적과 설계
• 응답자 프로파일

제2장 조사 결과

• 조사 결과

제3장 새로운 업계 동향

• 새로운 업계 동향 : 조사 결과 개요
• 게노믹스에 스포트라이트

영문목차

As industries emerge from the impact of COVID-19, 2022 will be a year of readjustments and transition for many businesses worldwide. While the ongoing COVID-19 pandemic continues to restrain economic recovery, pharmaceutical companies will continue to leverage innovative technology to enable and accelerate business growth, enhance resilience, and remain competitive in this heavily disrupted business landscape.

In this "State of the Biopharmaceutical Industry 2022" report, GlobalData examines the business environment and trends that are going to shape the biopharmaceutical industry in 2022. The report highlights the most impactful emerging technologies, industry, regulatory, and microeconomic factors that are going to impact and dominate the industry throughout 2022.

Scope

• The research source in this report is based on the opinions and expectations of 177 global healthcare industry professionals surveyed from November 17, 2021, to December 17, 2021, to gauge the 2022 outlook of the pharmaceutical industry. Respondents rated the anticipated impact of emerging industry, regulatory, macroeconomic and technology trends on the pharmaceutical industry during upcoming 12 months.
• Components of the report include:
• Emerging Industry Trends - a snapshot of current attitudes of business leaders towards the emerging industry trends and how they are shaping the future of healthcare industry
• Emerging Regulatory and Macroeconomic Trends - overview of the hindrances and drivers that will affect the state of biopharmaceutical industry
• Emerging technologies - highlights emerging technologies that are expected to have the greatest impact on biopharmaceutical industry in the next 12 months
• Industry's Growth Prospects - industry growth outlook: provides executives' opinions on the growth prospects of biopharmaceutical industry over the next 12 months
• Watch Outs - key industry shake-ups and trends to watch that represent both challenge and opportunity to the industry

Reasons to Buy

• Stay up to date with the major emerging technologies, regulatory, macroeconomic and industry trends that will impact the pharmaceutical industry in 2022.
• Explore how the biopharmaceutical landscape has changed.
• Identify the most impactful anticipated regulatory approvals and drug launches in the industry in 2022.
• Gain insight into the regulatory and microeconomics trends that well have the positive and negative effect on biopharmaceutical industry.
• Identify emerging industry trends and innovations to gain a competitive advantage.

Table of Contents

Table of Contents

1 Study Design

• 1.1 Respondent Mix
• 1.2 Objectives and Design
• 1.3 Respondent Profiles

2 Key Findings

• 2.1 Key Findings

3 Emerging Industry Trends

• 3.1 Emerging Industry Trends - Overview of Survey Results
• 3.2 Spotlight on Genomics
• 3.3 Spotli